Getting patients to stick to their prescribed medication regimen can be a huge problem for healthcare professionals. This can have negative complications for the patient, including increased healthcare costs, complications, and even death. AdhereTech have come up with a solution to this problem in the form of a sensor wireless pill bottle.
AdhereTech’s pill bottles are the same size and feel of a regular bill bottle and can be used straight out of the box, requiring no setup. Using sensors, the pill bottle can detect when a patient removes one pill or one liquid millimeter of medication. If no medication is taken, the service will remind the patient via an automated text message or phone call. There are also on-bottle lights and chimes that can alert the patient that they have missed their medication. The bottle constantly collects and send real-time data to the system, which is analyzed and populated on AdhereTech’s secure dashboard. The smart pill bottles are currently being used in pilot programs with pharmaceutical companies, pharmacies, and hospitals.
AdhereTech smart wireless pill bottles are currently being used by patients in pharmaceutical and research engagements. These bottles collect and send all adherence data in real-time. The system automatically analyzes this information and populates the data on our secure dashboard. If doses are missed, patients can receive customizable alerts and interventions – using automated phone calls, text messages, and more.
AdhereTech was launched while Mr Stein was completing the MBA programme at the University of Pennsylvania’s Wharton School.
Putting intelligence into everyday objects, as AdhereTech has done, is widely regarded in Silicon Valley as the next big evolution of online technology. By compiling usage information, which Mr Stein stresses is anonymised and compliant with data protection rules, AdhereTech has also become a data-driven business with valuable information otherwise unavailable to its clients.
AdhereTech’s customers include several of the largest US pharmaceutical companies, a national pharmacy chain, and both New York and Boston’s health system operators.
He gained a place on Blueprint Health, a New York-based accelerator programme focused on helping early-stage healthcare businesses. It was here Mr Stein and his team built a working prototype and lined up trials.